Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: A multi-model study (Q150164)

From geokb
a Article (Journal Article) published by Elsevier as part of series - The Lancet Regional Health - Americas
Language Label Description Also known as
English
Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: A multi-model study
a Article (Journal Article) published by Elsevier as part of series - The Lancet Regional Health - Americas

    Statements